Home
Our Company
Our Story
Our Leadership
Our Impacts
Our Science
Pipeline
Disease Area
Mechanism of Action
Media
Press Releases
Investors
Our Investors
Contact Us
General Enquiries
Follow Us
Media
Press Releases
Shanton Screens First Subjects in Phase 2b Refrac
Jan 09, 2023
Shanton Pharma Raised $31.2 Million in Series A+ Financing
Feb 09, 2021
